Main Article Content
Abstract
Type 2 diabetes mellitus (T2DM) is a chronic disease that may affect physical, psychological, and social well-being, thereby influencing patients’ quality of life. This study aimed to analyze the relationship between medication adherence and stress levels with quality of life among patients with T2DM in primary healthcare. A quantitative analytical observational study with a cross-sectional approach was conducted among 83 patients with T2DM selected using purposive sampling. Medication adherence was measured using the Morisky Medication Adherence Scale (MMAS-8), stress levels using the Perceived Stress Scale (PSS-10), and quality of life using the Diabetes Quality of Life–Brief Clinical Inventory (DQoL-BCI). Data were analyzed using Chi-square tests with a significance level of p ≤ 0.05. Most respondents demonstrated high medication adherence (47.0%), low stress levels (47.0%), and high quality of life (48.2%). There was a significant relationship between medication adherence and quality of life (p = 0.005). Respondents with higher medication adherence tended to report better quality of life. Stress level was also significantly associated with quality of life (p = 0.032), where higher stress levels were associated with poorer quality of life. Medication adherence and stress levels were significantly associated with quality of life among patients with T2DM. These findings highlight the importance of integrating adherence support and psychosocial management into diabetes care in primary healthcare settings.
Keywords
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
JKEP (Jurnal Keperawatan)
References
Care D, Suppl SS. Introduction and Methodology : Standards of Care in Diabetes — 2024. 2024;47(December 2023):1–4.
World Health Organization (WHO). Diabetes [Internet]. 2023. Available from: https://www.who.int/healthtopics/diabetes#tab=tab_1
IDF. Diabetes Atlas 11th Edition. Diabetes Atlas 11th Edition. 2025. 1–399 p.
Rodríguez-Aguilar Y, López-Guzmán O, Padilla-Raygoza N, Hernández-Jaime E, Sánchez-Castillo Y, Amador-Espinosa M, et al. Analysis of the Effect of Therapeutic Adherence on Quality of Life in Patients with Type 2 Diabetes: A Cross-Sectional Study. Int J Trop Dis Heal. 2025;46:76–90.
Yang H, Wu F, Gui M, Cheng Y, Zhang L. The role of medication adherence in the association between depressive symptoms and quality of life in older adults with type 2 diabetes mellitus. BMC Geriatr. 2023 Mar;23(1):196.
Vafopoulou E, Christodoulou N, Papathanasiou I V. Treatment Adherence and Quality of Life Among Elderly Patients With Diabetes Mellitus Registered in the Community. Cureus. 2024 Apr;16(4):e58986.
Chantzaras A, Yfantopoulos J. Association between medication adherence and health-related quality of life of patients with diabetes. Hormones (Athens). 2022 Dec;21(4):691–705.
Mishra R, Sharma SK, Verma R, Kangra P, Dahiya P, Kumari P, et al. Medication adherence and quality of life among type-2 diabetes mellitus patients in India. World J Diabetes. 2021 Oct;12(10):1740–9.
Li X, Wu L, Yun J, Sun Q. The status of stigma in patients with type 2 diabetes mellitus and its association with medication adherence and quality of life in China: A cross-sectional study. Medicine (Baltimore) [Internet]. 2023;102(26). Available from: https://journals.lww.com/md-journal/fulltext/2023/06300/the_status_of_stigma_in_patients_with_type_2.16.aspx
Turen S. The Relationship with Acceptance of Illness and Medication Adherence in Type 2 Diabetes Mellitus Patients. 2021;14(3):1824–32.
Huang J, Ding S, Xiong S, Liu Z. Medication Adherence and Associated Factors in Patients With Type 2 Diabetes : A Structural Equation Model. 2021;9(November):1–11.
Mahajan A, Muley A. Assessment of lifestyle factors , stress levels , and quality of life among people with Type 2 Diabetes Mellitus. Discov Public Heal [Internet]. 2024; Available from: https://doi.org/10.1186/s12982-024-00173-2
Abualhamael S, Baig M, Alghamdi W, Gazzaz Z, Al-Hayani M, Bazi A. Quality of life, stress, anxiety and depression and associated factors among people with type 2 diabetes mellitus in Western region Saudi Arabia. Front Psychiatry [Internet]. 2024;14. Available from: https://consensus.app/papers/quality-of-life-stress-anxiety-and-depression-and-al-hayani-baig/1b1a302a1d8e540fb59fa51d9ec3661d/
Lo Monaco M, Profeta A, Corrao S. Telenursing as an Effective Ally for Improving Patient Outcomes in Diabetes? An Umbrella Review. Nurs open. 2025 Jul;12(7):e70265.
Elayyan B, Abuhalima D, Al-Jabi SW, Zyoud SH. Association of medication adherence and glycemic control with pain severity among patients with diabetes mellitus: a cross-sectional study from Palestine. BMC Endocr Disord. 2025 Jul;25(1):180.
Yorke E, Boima V, Ganu V, Tetteh J, Twumasi L, Ekem-Ferguson G, et al. The mediating role of quality of life on depression and medication adherence among patients with type 2 diabetes mellitus: A cross-sectional study. Heal Sci reports. 2023 Sep;6(9):e1539.
Khayyat SM, Mohamed MMA, Saeed SM, Raghda K, Alhazmi SH. Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics : a cross-sectional survey. Qual Life Res [Internet]. 2018;0(0):0. Availablefrom:http://dx.doi.org/10.1007/s11136-018-2060-8
Majeed A, Rehman M, Hussain I, Imran I, Saleem MU, Saeed H, et al. The Impact of Treatment Adherence on Quality of Life Among Type 2 Diabetes Mellitus Patients - Findings from a Cross-Sectional Study. Patient Prefer Adherence. 2021;15:475–81.
Pazokian M, Beigmoradi S, Movafegh F, Akbarzadeh S. Correlation between Social Support and Hope with Medication Adherence in Type II Diabetic Patients. 2020;11:130–5.
Susanti W, Handoko G, Isnawati IA. Hubungan Dukungan Keluarga, Kepatuhan Minum Obat dan Tingkat Stres dengan Kualitas Hidup Pada Pasien Diabetes Mellitus Tipe II di RSUD Soedarsono. J Ilmu Kesehat [Internet]. 2023;2(10):266–76. Available from: https://journal.mandiracendikia.com/index.php/JIK-MC/article/view/614/490
Martino G, Catalano A, Bellone F, Russo GT, Vicario CM, Lasco A, et al. As Time Goes by : Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration. 2019;10(July):1–8.
Thirunavukkarasu, A., Alharbi, M. S., Salahuddin, M., Al-Hazmi, A. H., ALruwaili, B. F., Alsaidan, A. A., ... & Alrashoudi LI. Evaluation of oral health-related quality of life and its association with mental health status of patients with type 2 diabetes mellitus in the post-COVID-19 pandemic era : A study from Central Saudi Arabia. 2025;(March).
Świątoniowska-Lonc, N., Tański, W., Polański, J., Jankowska-Polańska, B., & Mazur G. Psychosocial Determinants of Treatment Adherence in Patients with Type 2 Diabetes – A Psychosocial Determinants of Treatment Adherence in Patients with Type 2 Diabetes – A Review. 2021;7007.
Sanan, Y. C. U., & Nitsae V. THE EFFECT OF TELEMONITORING ON DIABETES DISTRESS IN PATIENTS WITH TYPE II DIABETES MELLITUS IN RI-RDTL BORDER. 2025;10(1):8–12.